Eli Lilly doubles down on its pipeline with new data for weight-loss pill Foundayo and next-generation combo drug EloraTZP. Continue Reading
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。

Eli Lilly doubles down on its pipeline with new data for weight-loss pill Foundayo and next-generation combo drug EloraTZP. Continue Reading
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。